Controlled Substances Market By Drug Class (Opioids, Stimulants, Depressants, Marijuana), By Application ( ADHD, Pain Management, Depression, Seizures, Anxiety, Others), By Distribution Channel (Institutional Sales, Retail Sales), and by Region - Global Market Insights 2023 to 2033

Publish Date: Mar 2023

Report Code: FMR246B

Publisher: Fact Market Research

Single User License: $4500

Explore Our Services

Already a member? Login here.

Report Highlights

Controlled Substances Market - Scope of Report

A recent study by Fact.MR on the controlled substances market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering controlled substances.

The study also provides the dynamics responsible for influencing the future status of the controlled substances market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the controlled substances market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of controlled substances across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of controlled substances during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for controlled substances are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global controlled substances market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the controlled substances market during the forecast period.

Country-specific valuation on demand for controlled substances has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of controlled substances, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering controlled substances has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the controlled substances domain.

  • Table 1 : Pipeline Assessment for Stimulants
  • Table 2 : Expenditure on Health, (% of GDP), by Country, 2018–2022
  • Table 3 : Expenditure on Health, (% of GDP), by Country, 2018–2022
  • Table 4 : Global Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 5 : Global Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 6 : Global Market Analysis 2018-2022 and Forecast 2023-2033, By Application
  • Table 7 : Global Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
  • Table 8 : Global Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 By Region
  • Table 9 : North America Market Analysis 2018-2022 and Forecast 2023-2033, By Country
  • Table 10 : North America Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 11 : North America Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 12 : North America Market Analysis 2018-2022 and Forecast 2023-2033, By Application
  • Table 13 : North America Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
  • Table 14 : Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Country
  • Table 15 : Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 16 : Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 17 : Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Application
  • Table 18 : Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
  • Table 19 : Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Country
  • Table 20 : Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 21 : Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 22 : Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Application
  • Table 23 : Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
  • Table 24 : East Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Country
  • Table 25 : East Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 26 : East Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 27 : East Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Application
  • Table 28 : East Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
  • Table 29 : South Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Country
  • Table 30 : South Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 31 : South Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 32 : South Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Application
  • Table 33 : South Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
  • Table 34 : Oceania Market Analysis 2018-2022 and Forecast 2023-2033, By Country
  • Table 35 : Oceania Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 36 : Oceania Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 37 : Oceania Market Analysis 2018-2022 and Forecast 2023-2033, By Application
  • Table 38 : Oceania Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
  • Table 39 : MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Country
  • Table 40 : MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 41 : MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 42 : MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Application
  • Table 43 : MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
  • Table 44 : Emerging Market Value Proportion Analysis 2018-2022 and Forecast 2023-2033, By Country vs Global value
  • Table 45 : India Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 46 : India Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 47 : India Market Analysis 2018-2022 and Forecast 2023-2033, By Application
  • Table 48 : India Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
  • Table 49 : South Africa Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 50 : South Africa Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 51 : South Africa Market Analysis 2018-2022 and Forecast 2023-2033, By Application
  • Table 52 : South Africa Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
  • Table 53 : Brazil Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 54 : Brazil Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class
  • Table 55 : Brazil Market Analysis 2018-2022 and Forecast 2023-2033, By Application
  • Table 56 : Brazil Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
  • Figure 1 : Pipeline Assessment For Opioids, By phase
  • Figure 2 : Pipeline Assessment For Opioids, By Trial Status
  • Figure 3 : Pipeline Assessment For Stimulants, By phase
  • Figure 4 : Pipeline Assessment For Stimulants, By Trial Status
  • Figure 5 : Medical Marijuana Patent Citations Analysis, 2018–2022, By Country
  • Figure 6 : Medical Marijuana Patent Citations Analysis, from 2023–2033
  • Figure 7 : Global Market Value Analysis and Forecast, 2018–2033 (US$ Mn)
  • Figure 8 : Global Market Absolute $ Opportunity (US$ Mn), 2018–2022
  • Figure 9 : Global Market Absolute $ Opportunity (US$ Mn), 2018–2033
  • Figure 10 : Global Market Share%, by Drug Class, 2022E - Opioids
  • Figure 11 : Global Market Share%, by Drug Class, 2022E - Stimulants
  • Figure 12 : Global Market Share%, by Drug Class, 2022E - Depressants
  • Figure 13 : Global Market Share%, by Drug Class, 2022E - Marijuana
  • Figure 14 : Global Market Size (US$ Mn) Analysis, 2018–2022, by Opioids
  • Figure 15 : Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids
  • Figure 16 : Global Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants
  • Figure 17 : Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants
  • Figure 18 : Global Market Size (US$ Mn) Analysis, 2018–2022, by Depressants
  • Figure 19 : Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants
  • Figure 20 : Global Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana
  • Figure 21 : Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana
  • Figure 22 : Global Market Attractiveness Analysis, By Drug Class
  • Figure 23 : Global Market Attractiveness Analysis, By Application
  • Figure 24 : Global Market Attractiveness Analysis, By Distribution Channel
  • Figure 25 : Global Market Incremental Opportunity US$, by Region, 2018-2033
  • Figure 26 : Market Share%, by Region, 2022E
  • Figure 27 : Global Market Absolute Opportunity US$, by Region, 2023-2033
  • Figure 28 : Market Share%, by Region, 2033F
  • Figure 29 : Global Market Attractiveness Analysis, By Region
  • Figure 30 : North America Market size (US$ Mn) Analysis, 2018–2022
  • Figure 31 : North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 32 : US Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 33 : US Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 34 : Canada Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 35 : Canada Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 36 : North America Market Size (US$ Mn) Analysis, 2018–2022, by Opioids
  • Figure 37 : North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids
  • Figure 38 : North America Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants
  • Figure 39 : North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants
  • Figure 40 : North America Market Size (US$ Mn) Analysis, 2018–2022, by Depressants
  • Figure 41 : North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants
  • Figure 42 : North America Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana
  • Figure 43 : North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana
  • Figure 44 : North America Market Attractiveness Analysis, By Drug Type
  • Figure 45 : North America Market Attractiveness Analysis, By Application
  • Figure 46 : North America Market Attractiveness Analysis, By Distribution Channel
  • Figure 47 : North America Market Attractiveness Analysis, By Country
  • Figure 48 : Latin America Market size (US$ Mn) Analysis, 2018–2022
  • Figure 49 : Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 50 : Brazil Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 51 : Brazil Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 52 : Mexico Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 53 : Mexico Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 54 : Rest of Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 55 : Rest of Latin America Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 56 : Latin America Market Size (US$ Mn) Analysis, 2018–2022, by Opioids
  • Figure 57 : Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids
  • Figure 58 : Latin America Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants
  • Figure 59 : Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants
  • Figure 60 : Latin America Market Size (US$ Mn) Analysis, 2018–2022, by Depressants
  • Figure 61 : Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants
  • Figure 62 : Latin America Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana
  • Figure 63 : Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana
  • Figure 64 : Latin America Market Attractiveness Analysis, By Drug Type
  • Figure 65 : Latin America Market Attractiveness Analysis, By Application
  • Figure 66 : Latin America Market Attractiveness Analysis, By Distribution Channel
  • Figure 67 : Latin America Market Attractiveness Analysis, By Country
  • Figure 68 : Europe Market size (US$ Mn) Analysis, 2018–2022
  • Figure 69 : Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 70 : U.K. Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 71 : U.K. Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 72 : Germany Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 73 : Germany Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 74 : France Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 75 : France Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 76 : Italy Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 77 : Italy Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 78 : Spain Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 79 : Spain Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 80 : BENELUX Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 81 : BENELUX Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 82 : Russia Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 83 : Russia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 84 : Rest of Europe Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 85 : Rest of Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 86 : Europe Market Size (US$ Mn) Analysis, 2018–2022, by Opioids
  • Figure 87 : Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids
  • Figure 88 : Europe Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants
  • Figure 89 : Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants
  • Figure 90 : Europe Market Size (US$ Mn) Analysis, 2018–2022, by Depressants
  • Figure 91 : Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants
  • Figure 92 : Europe Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana
  • Figure 93 : Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana
  • Figure 94 : Europe Market Attractiveness Analysis, By Drug Type
  • Figure 95 : Europe Market Attractiveness Analysis, By Application
  • Figure 96 : Europe Market Attractiveness Analysis, By Distribution Channel
  • Figure 97 : Europe Market Attractiveness Analysis, By Country
  • Figure 98 : East Asia Market size (US$ Mn) Analysis, 2018–2022
  • Figure 99 : East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 100 : China Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 101 : China Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 102 : Japan Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 103 : Japan Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 104 : South Korea Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 105 : South Korea Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 106 : East Asia Market Size (US$ Mn) Analysis, 2018–2022, by Opioids
  • Figure 107 : East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids
  • Figure 108 : East Asia Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants
  • Figure 109 : East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants
  • Figure 110 : East Asia Market Size (US$ Mn) Analysis, 2018–2022, by Depressants
  • Figure 111 : East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants
  • Figure 112 : East Asia Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana
  • Figure 113 : East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana
  • Figure 114 : East Asia Market Attractiveness Analysis, By Drug Type
  • Figure 115 : East Asia Market Attractiveness Analysis, By Application
  • Figure 116 : East Asia Market Attractiveness Analysis, By Distribution Channel
  • Figure 117 : East Asia Market Attractiveness Analysis, By Country
  • Figure 118 : South Asia Market size (US$ Mn) Analysis, 2018–2022
  • Figure 119 : Global Donor Egg IVF Market Attractiveness Analysis by Region , 2023-2033
  • Figure 120 : South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 121 : India Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 122 : India Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 123 : Thailand Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 124 : Thailand Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 125 : Indonesia Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 126 : Indonesia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 127 : Malaysia Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 128 : Malaysia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 129 : Rest of South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 130 : Rest of South Asia Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 131 : South Asia Market Size (US$ Mn) Analysis, 2018–2022, by Opioids
  • Figure 132 : South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids
  • Figure 133 : South Asia Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants
  • Figure 134 : South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants
  • Figure 135 : South Asia Market Size (US$ Mn) Analysis, 2018–2022, by Depressants
  • Figure 136 : South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants
  • Figure 137 : South Asia Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana
  • Figure 138 : South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana
  • Figure 139 : South Asia Market Attractiveness Analysis, By Drug Type
  • Figure 140 : South Asia Market Attractiveness Analysis, By Application
  • Figure 141 : South Asia Market Attractiveness Analysis, By Distribution Channel
  • Figure 142 : South Asia Market Attractiveness Analysis, By Country
  • Figure 143 : Oceania Market size (US$ Mn) Analysis, 2018–2022
  • Figure 144 : Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 145 : Australia Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 146 : Australia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 147 : New Zealand Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 148 : New Zealand Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 149 : Oceania Market Size (US$ Mn) Analysis, 2018–2022, by Opioids
  • Figure 150 : Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids
  • Figure 151 : Oceania Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants
  • Figure 152 : Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants
  • Figure 153 : Oceania Market Size (US$ Mn) Analysis, 2018–2022, by Depressants
  • Figure 154 : Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants
  • Figure 155 : Oceania Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana
  • Figure 156 : Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana
  • Figure 157 : Oceania Market Attractiveness Analysis, By Drug Type
  • Figure 158 : Oceania Market Attractiveness Analysis, By Application
  • Figure 159 : Oceania Market Attractiveness Analysis, By Distribution Channel
  • Figure 160 : Oceania Market Attractiveness Analysis, By Country
  • Figure 161 : MEA Market size (US$ Mn) Analysis, 2018–2022
  • Figure 162 : MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 163 : South Africa Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 164 : South Africa Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 165 : GCC Countries Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 166 : GCC Countries Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 167 : Rest of MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 168 : Rest of MEA Market Size (US$ Mn) Analysis, 2018–2022
  • Figure 169 : MEA Market Size (US$ Mn) Analysis, 2018–2022, by Opioids
  • Figure 170 : MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids
  • Figure 171 : MEA Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants
  • Figure 172 : MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants
  • Figure 173 : MEA Market Size (US$ Mn) Analysis, 2018–2022, by Depressants
  • Figure 174 : MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants
  • Figure 175 : MEA Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana
  • Figure 176 : MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana
  • Figure 177 : MEA Market Attractiveness Analysis, By Drug Type
  • Figure 178 : MEA Market Attractiveness Analysis, By Application
  • Figure 179 : MEA Market Attractiveness Analysis, By Distribution Channel
  • Figure 180 : MEA Market Attractiveness Analysis, By Country
  • Figure 181 : Market Value Proportion Analysis, By Key Countries, 2022E
  • Figure 182 : Global Vs. Country, Y-O-Y Growth Comparison
  • Figure 183 : India Market size (US$ Mn) Analysis, 2018–2022
  • Figure 184 : India Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 185 : India Market Attractiveness Analysis, By Drug Class
  • Figure 186 : India Market Attractiveness Analysis, By Application
  • Figure 187 : India Market Attractiveness Analysis, By Distribution Channel
  • Figure 188 : South Africa Market size (US$ Mn) Analysis, 2018–2022
  • Figure 189 : South Africa Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 190 : South Africa Market Attractiveness Analysis, By Drug Class
  • Figure 191 : South Africa Market Attractiveness Analysis, By Application
  • Figure 192 : South Africa Market Attractiveness Analysis, By Distribution Channel
  • Figure 193 : Brazil Market size (US$ Mn) Analysis, 2018–2022
  • Figure 194 : Brazil Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033
  • Figure 195 : Brazil Market Attractiveness Analysis, By Drug Class
  • Figure 196 : Brazil Market Attractiveness Analysis, By Application
  • Figure 197 : Brazil Market Attractiveness Analysis, By Distribution Channel

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Similar Reports from Fact Market Research

Controlled Substances Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028

  • Date - Mar 2019
  • Code - FMR246A

This Fact.MR study delivers a comprehensive analysis of the controlled substances market, along with a detailed &accurate forecast of the market between the period 2018 and 2028. Key aspects affecting growth of the controlled substances market have been analyzed and their degree of impact on demand for controlled substances worldwide have been evaluated. The report further highlights macro- and micro-economic ...

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Controlled Substances Market By Drug Class (Opioids, Stimulants, Depressants, Marijuana), By Application ( ADHD, Pain Management, Depression, Seizures,...